Dr Scott Tagawa discusses how dose adjustments can optimize the use of enfortumab vedotin in urothelial cancer.

Researchers analyzed data on 215 women diagnosed with stages 0-III breast cancer between January 2000 and October 2024 who ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and patient-important outcomes.

A prehospital blood test may rapidly distinguish between ischemic and hemorrhagic strokes, potentially enabling more timely, ...

Although it may feel good in the moment, a repetitive cycle of boosting your cortisol levels and seeking solace in food can ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.

The clinical practice update offers 12 “best practice advice” statements on POEM to treat achalasia and other esophageal ...

A real-world Danish registry study showed a significant increased relative risk, but small absolute risk, for stroke and ...

A transradial approach for cerebral angiography was less effective than the transfemoral route in achieving an accurate diagnostic success rate.

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...